Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Non-Current Assets (2018 - 2026)

Nomad Power Solutions (NMAD) posted Non-Current Assets of $7.3 million for Q2 2026, down 2.72% on a QoQ basis from $7.6 million in Q4 2025, and up 3596.62% year-over-year from $198826.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Non-Current Assets (2018 - 2026) Analysis & Trends

Nomad Power Solutions has reported Non-Current Assets for 7 years, with the latest figure at $7.3 million in Q2 2026.

  • On a quarterly basis, Non-Current Assets rose 3596.62% year-over-year to $7.3 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a 7240.76% increase from a year earlier, with the FY2025 full-year figure at $7.6 million, changed N/A from the prior year.
  • Non-Current Assets was $7.3 million for Q2 2026 at Nomad Power Solutions, down from $7.6 million in the prior quarter.
  • The five-year high for Non-Current Assets was $7.6 million in Q4 2025, with the low at $6928.0 in Q3 2024.
  • Average Non-Current Assets over 4 years is $3.0 million, with a median of $198826.0 recorded in 2025.
  • The largest YoY upside for Non-Current Assets was 3596.62% in 2026 against a maximum downside of 3596.62% in 2026.
  • Over 4 years, Non-Current Assets stood at $10906.0 in 2022, then tumbled by 36.48% to $6928.0 in 2024, then soared by 108953.72% to $7.6 million in 2025, then fell by 2.72% to $7.3 million in 2026.
  • The last three Non-Current Assets figures came in at $7.3 million (Q2 2026), $7.6 million (Q4 2025), and $198826.0 (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 564.41 Mn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 7.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.35 Mn
Dec 31, 2025 7.56 Mn
Jun 30, 2025 198,826.00
Sep 30, 2024 6,928.00
Mar 31, 2022 10,906.00
Sep 30, 2021 26,376.00
Sep 30, 2020 174,253.00
Jun 30, 2020 86,850.00
Dec 31, 2018 2,293.00
Sep 30, 2018 4,587.00
Jun 30, 2018 6,880.00